A pan-cancer metabolic atlas of the tumor microenvironment

Cell Rep. 2022 May 10;39(6):110800. doi: 10.1016/j.celrep.2022.110800.

Abstract

Tumors are heterogeneous cellular environments with entwined metabolic dependencies. Here, we use a tumor transcriptome deconvolution approach to profile the metabolic states of cancer and non-cancer (stromal) cells in bulk tumors of 20 solid tumor types. We identify metabolic genes and processes recurrently altered in cancer cells across tumor types, highlighting pan-cancer upregulation of deoxythymidine triphosphate (dTTP) production. In contrast, the tryptophan catabolism rate-limiting enzymes IDO1 and TDO2 are highly overexpressed in stroma, raising the hypothesis that kynurenine-mediated suppression of antitumor immunity may be predominantly constrained by the stroma. Oxidative phosphorylation is the most upregulated metabolic process in cancer cells compared to both stromal cells and a large atlas of cancer cell lines, suggesting that the Warburg effect may be less pronounced in cancer cells in vivo. Overall, our analysis highlights fundamental differences in metabolic states of cancer and stromal cells inside tumors and establishes a pan-cancer resource to interrogate tumor metabolism.

Keywords: CP: Cancer; CP: Metabolism; metabolism; tumor microenvironment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Humans
  • Kynurenine / metabolism
  • Neoplasms* / genetics
  • Stromal Cells / metabolism
  • Tryptophan Oxygenase / genetics
  • Tryptophan Oxygenase / metabolism
  • Tumor Microenvironment*

Substances

  • Kynurenine
  • Tryptophan Oxygenase